Directory
>
Rogério Vivaldi Md
Rogério Vivaldi Md
Member Board of Directors | Crinetics Pharmaceuticals
Cambridge, Massachusetts, United States
Rogério Vivaldi Md
Summary
Dr. Rogério Vivaldi is an accomplished leader in the pharmaceutical and biotechnology sectors, with a unique blend of medical and business expertise. He holds an MBA and has a rich background in biologics, clinical development, and market access, particularly in the context of rare diseases and neurology. As a board member for multiple companies, including Viatris and Crinetics Pharmaceuticals, he leverages his extensive experience to drive innovation and strategic growth. His tenure as CEO at Sigilon Therapeutics underscores his commitment to pioneering new therapies that address significant unmet medical needs. With a career spanning over two decades, Rogério has consistently held senior leadership roles, shaping the landscape of therapeutic operations and commercialization. He is passionate about advancing Living Therapeutics, which promise safer and more effective treatments compared to traditional gene therapies. His work aims to enhance patient outcomes while navigating the complexities of regulatory affairs and market dynamics.
Rogério Vivaldi Md
Work Experience
Member Board of Directors at
Viatris, Inc.
June 2024 - Present
Board Member at
Vesper Biotechnologies
January 2024 - Present
CEO at
Vivaldi Rare Consulting
January 2024 - Present
Board Member at
Crinetics Pharmaceuticals
January 2022 - Present
Board Member at
Latinos in Bio
July 2021 - Present
President, CEO at
Sigilon Therapeutics, Inc.
August 2018 - September 2023
Chief Global Therapeutic Operations Officer at
Bioverativ, a Sanofi company
October 2016 - August 2018
Chief Commercial Officer at
Spark Therapeutics, Inc.
December 2014 - October 2016
President & CEO at
Minerva Neurosciences
November 2013 - December 2014
SVP, Head of Rare Diseases at
Sanofi
January 2012 - October 2013
President, Personalized Genetic Health (PGH) at
SANOFI-AVENTIS AUSTRALIA PTY LTD
July 2011 - December 2011
President, Renal & Endocrine at
Sanofi Genzyme
May 2010 - July 2011
Senior Vice President & General Manager, Latin America Group at
SANOFI-AVENTIS AUSTRALIA PTY LTD
January 2005 - May 2010
President, Chief Executive Officer at
Sigilon Therapeutics, Inc.
Present
Vice President & General manager Genzyme Brasil at
Sanofi Genzyme
January 1997 - December 2004
Rogério Vivaldi Md
Education
Universidade Federal do Rio de Janeiro, Master Of Business Administration (Mba)
January 1997 - January 1997
UNIVERSIDADE DO RIO DE JANEIRO, Medicine
January 1981 - January 1987
Frequently Asked Questions about Rogério Vivaldi Md
What is Rogério Vivaldi Md email address?
Rogério Vivaldi Md's primary email address is ********@sigilon.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Rogério Vivaldi Md work for?
Rogério Vivaldi Md is a Member Board of Directors at Crinetics Pharmaceuticals, a company specializing in Commercial physical research.
Where Rogério Vivaldi Md graduated from?
Rogério Vivaldi Md holds a degree in Mba from Universidade Federal do Rio de Janeiro.
How can I directly contact Rogério Vivaldi Md?
To contact Rogério Vivaldi Md directly, you can use the email address ********@sigilon.com. Complete contact information is available upon registration with Muraena.
Is Rogério Vivaldi Md an immigrant?
Yes, Rogério Vivaldi Md is an immigrant and currently based in United States
Who is Rogério Vivaldi Md?
Dr. Rogério Vivaldi is an accomplished leader in the pharmaceutical and biotechnology sectors, with a unique blend of medical and business expertise. He holds an MBA and has a rich background in biologics, clinical development, and market access, particularly in the context of rare diseases and neurology. As a board member for multiple companies, including Viatris and Crinetics Pharmaceuticals, he leverages his extensive experience to drive innovation and strategic growth. His tenure as CEO at Sigilon Therapeutics underscores his commitment to pioneering new therapies that address significant unmet medical needs. With a career spanning over two decades, Rogério has consistently held senior leadership roles, shaping the landscape of therapeutic operations and commercialization. He is passionate about advancing Living Therapeutics, which promise safer and more effective treatments compared to traditional gene therapies. His work aims to enhance patient outcomes while navigating the complexities of regulatory affairs and market dynamics.
Rogério`s contact details
********@sigilon.com
***************@genzyme.com
*********@crinetics.com
Colleagues
Vice President, Project, Portfolio and Alliance Management
Chief of Staff and Head of Portfolio Strategy
Vice President of Market Access
Executive Director, Head of Corporate Strategy
Scientific Advisory Board Member
Vice President, Health Economics and Outcomes Research
Biopharmaceutical Program Leader
Vice President, Regulatory Affairs and Quality Assurance
Vice President, Marketing - Rare Diseases
Vice President, Global Product Lead